Merck & Co. Inc. (MRK)
NYSE: MRK
· Real-Time Price · USD
85.64
-0.35 (-0.41%)
At close: Oct 13, 2025, 3:59 PM
85.40
-0.29%
Pre-market: Oct 14, 2025, 06:54 AM EDT
-0.41% (1D)
Bid | 85.49 |
Market Cap | 213.92B |
Revenue (ttm) | 63.62B |
Net Income (ttm) | 16.41B |
EPS (ttm) | 6.49 |
PE Ratio (ttm) | 13.2 |
Forward PE | 8.93 |
Analyst | Hold |
Dividends | $4.01 |
Ask | 85.74 |
Volume | 5,318,399 |
Avg. Volume (20D) | 14,834,489.7 |
Open | 85.66 |
Previous Close | 85.99 |
Day's Range | 85.24 - 86.46 |
52-Week Range | 73.31 - 111.58 |
Beta | 0.37 |
Ex-Dividend Date | Sep 15, 2025 |
Analyst Forecast
According to 0 analyst ratings, the average rating for MRK stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsMerck & Co. Inc. is scheduled to release its earnings on
Oct 30, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+7.39%
Shares of several drugmakers are trading higher af...
Unlock content with
Pro Subscription
1 week ago
+6.81%
Shares of several drugmakers are trading higher after President Trump announced a deal with Pfizer as well as the 'TrumpRx' site to decrease prices.